Cite
MLA Citation
G. Daniele et al.. “H01*A multicenter, randomised, phase 3 trial comparing fixed dose versus toxicity-adjusted dose of cisplatin + etoposide in advanced SCLC patients (pts). The STAD-1 trial.” Annals of oncology, vol. 26, n.d., p. vi. http://access.bl.uk/ark:/81055/vdc_100097082919.0x000021